Board Meeting10 Aug 2026, 07:20 pm
Jubilant Pharmova Board Approves Q1 FY27 Unaudited Financial Results
AI Summary
Jubilant Pharmova Ltd announced that its Board of Directors met on August 10, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026. The results, both standalone and consolidated, along with the limited review report, have been submitted. These documents will also be available on the company's official website. The meeting concluded after reviewing these financial statements.
Key Highlights
- Board meeting held on August 10, 2026.
- Unaudited financial results for Q1 FY27 approved.
- Both standalone and consolidated results were declared.
- Limited Review Report also approved and submitted.
- Financials will be posted on the company website.
Price Impact
More from JUBLPHARMA